Tetulomab tetraxetan Lu-177
(2S)-2-amino-6-[[4-[[1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetrazacyclododec-2-yl]methyl]phenyl]carbamothioylamino]hexanoic acid
Molecular Identity
Tetulomab tetraxetan Lu-177
(2S)-2-amino-6-[[4-[[1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetrazacyclododec-2-yl]methyl]phenyl]carbamothioylamino]hexanoic acid
PubChem CID: 131704322
2D Structure
Properties
C30H47N7O10S
Molecular Formula
697.80
Molecular Weight
g/mol
697.3105
Exact Mass
Da
-11.5
XLogP
Drug-like (Lipinski: < 5)
282
TPSA
May have limited oral absorption
8
H-Bond Donors
16
H-Bond Acceptors
1080
Complexity
SMILES
Canonical SMILES
SMILES: C1CN(CCN(C(CN(CCN1CC(=O)O)CC(=O)O)CC2=CC=C(C=C2)NC(=S)NCCCCC(C(=O)O)N)CC(=O)O)CC(=O)OIsomeric SMILES
SMILES: C1CN(CCN(C(CN(CCN1CC(=O)O)CC(=O)O)CC2=CC=C(C=C2)NC(=S)NCCCC[C@@H](C(=O)O)N)CC(=O)O)CC(=O)OSynonyms(15)
Tetulomab tetraxetan Lu-1776QU69VIG75177lu-tetulomab177Lu-Dota-Tetulomab(sup 177)lu-tetulomabRefChem:932871CPW7BR9UY7177lu-tetraxetan-tetulomab177Lu-HH1Lutetium Lu 177 DOTA-TetulomabANTI-CD37 ANTIBODY TETULOMAB TETRAXETAN LU-177(2S)-2-amino-6-(((4-((1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecan-2-yl)methyl)phenyl)carbamothioyl)amino)hexanoic acidBetalutinDB12227LYSINE .EPISILON.CARBAMOTHIOBENZYL-2-TETRAXAN
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tetulomab tetraxetan Lu-177
Loading drug network...